- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
YUPELRI - 175mcg/3ml - 7
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R03BB08 | B | Revefenacin - 175mcg/3ml | 10862 | 7921/1 | YUPELRI | 175mcg/3ml | 7 | Inhalation solution | Respiratory | Omnipharma | The Ritedose Corporation | USA | 3,104,276 L.L | 23.08 | B | Mylan Ireland Ltd | Ireland | 2/5/2024 | 0 |